"Upon examining the results, the study found that suicidality among these patients "significantly declined from pretreatment to post-treatment," and was "consistent across sex assigned at birth, age at start of therapy, and treatment duration." The study included all youth who initiated hormone treatment therapy during the years 2017 to 2024 at the medical center in question. The average follow-up to the surveys the patients took occurred around two years after their treatment began, with some patients providing feedback up to five years after they started."
"Suicidality scores among the patients who provided responses dropped by over 67 percent, the study discovered. What's more, of the hundreds of patients who started hormone therapy, only seven discontinued their treatment, with four saying they had a "shift in gender identity" (while still identifying as gender diverse), and one stopping out of concerns over "hair loss." Two stopped for unknown reasons."
Data from 432 transgender patients aged 12 to 20 who initiated gender-affirming hormone therapy between 2017 and 2024 at a Midwestern academic medical center show substantial declines in suicidality. Patients completed Ask Suicide-Screening Questions (ASQ) prior to hormone therapy and again at follow-up visits. Average follow-up occurred around two years after treatment initiation, with some responses up to five years later. Suicidality scores among respondents declined by over 67 percent and the reduction was consistent across sex assigned at birth, age at therapy start, and treatment duration. Seven patients discontinued therapy for various reasons, including identity shifts and hair loss concerns.
Read at Truthout
Unable to calculate read time
Collection
[
|
...
]